EagleClaw Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.34M | Buy |
1,715
+7
| +0.4% | +$5.46K | 0.2% | 86 |
|
|
2025
Q1 | $1.41M | Sell |
1,708
-10
| -0.6% | -$8.26K | 0.22% | 83 |
|
|
2024
Q4 | $1.33M | Hold |
1,718
| – | – | 0.21% | 83 |
|
|
2024
Q3 | $1.52M | Sell |
1,718
-7
| -0.4% | -$6.2K | 0.25% | 79 |
|
|
2024
Q2 | $1.56M | Hold |
1,725
| – | – | 0.28% | 80 |
|
|
2024
Q1 | $1.34M | Sell |
1,725
-60
| -3% | -$46.7K | 0.24% | 82 |
|
|
2023
Q4 | $1.04M | Hold |
1,785
| – | – | 0.22% | 83 |
|
|
2023
Q3 | $959K | Hold |
1,785
| – | – | 0.22% | 81 |
|
|
2023
Q2 | $837K | Sell |
1,785
-25
| -1% | -$11.7K | 0.19% | 88 |
|
|
2023
Q1 | $622K | Buy |
1,810
+185
| +11% | +$63.5K | 0.15% | 94 |
|
|
2022
Q4 | $594K | Buy |
1,625
+975
| +150% | +$357K | 0.14% | 93 |
|
|
2022
Q3 | $210K | Hold |
650
| – | – | 0.06% | 123 |
|
|
2022
Q2 | $211K | Sell |
650
-50
| -7% | -$16.2K | 0.06% | 123 |
|
|
2022
Q1 | $200K | Sell |
700
-50
| -7% | -$14.3K | 0.05% | 134 |
|
|
2021
Q4 | $207K | Buy |
+750
| New | +$207K | 0.05% | 138 |
|